# A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

> **NCT02594267** · PHASE1 · COMPLETED · sponsor: **Acrotech Biopharma Inc.** · enrollment: 48 (actual)

## Conditions studied

- Peripheral T-Cell Lymphoma (PTCL)

## Interventions

- **DRUG:** Pralatrexate Injection

## Key facts

- **NCT ID:** NCT02594267
- **Lead sponsor:** Acrotech Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-10
- **Primary completion:** 2017-04-07
- **Final completion:** 2020-10-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594267, "A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02594267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*